Evaluation of Safety and Effectiveness of the EMBLOK EPS Compared With No Cerebral Embolic Protection During TAVR

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Evaluation of Safety and Effectiveness of the EMBLOK EPS Compared With No Cerebral Embolic Protection During TAVR	aortic valve disorder, aortic valve insufficiency, cardiovascular disorder, heart disorder, heart valve disorder	Not yet recruiting	Not applicable	2025-08-19		NCT07129421

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Emblok, Inc.	2
Yale Cardiovascular Research Group	11

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials